Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,487 results for ""Chemokine CXCL9""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.

  • Authors : Seo DH; San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA, USA.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.

Subjects: Muscle Strength*/Muscle Strength*/Muscle Strength*/physiology ; Osteoporotic Fractures*/Osteoporotic Fractures*/Osteoporotic Fractures*/blood ; Osteoporotic Fractures*/Osteoporotic Fractures*/Osteoporotic Fractures*/physiopathology

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer.

  • Authors : Liao W; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.; Liu T

Subjects: Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/genetics ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/pathology ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/metabolism

  • Source: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology [J Obstet Gynaecol] 2024 Dec; Vol. 44 (1), pp. 2373951. Date of Electronic Publisher: Informa Healthcare Country of Publication: England NLM ID: 8309140 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus.

  • Authors : Kersh AE; Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.; Sati S

Subjects: Chemokine CCL19*/Chemokine CCL19*/Chemokine CCL19*/metabolism ; Lichen Planus*/Lichen Planus*/Lichen Planus*/immunology ; Lichen Planus*/Lichen Planus*/Lichen Planus*/pathology

  • Source: JCI insight [JCI Insight] 2024 Oct 22; Vol. 9 (20). Date of Electronic Publication: 2024 Oct 22.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop.

Subjects: Receptors, CXCR3*/Receptors, CXCR3*/Receptors, CXCR3*/metabolism ; Receptors, CXCR3*/Receptors, CXCR3*/Receptors, CXCR3*/genetics ; Chemokine CXCL9*/Chemokine CXCL9*/Chemokine CXCL9*/metabolism

  • Source: Frontiers in immunology [Front Immunol] 2024 Oct 15; Vol. 15, pp. 1452212. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Subjects: Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/immunology ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/virology ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/drug therapy

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4505-4516.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Role of PD-1 in modulating IFN-γ-CXCL9/10-CXCR3 signaling in breast cancer.

  • Authors : Hong L; Department of Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.; Huang F

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism

  • Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Dec; Vol. 38 (12), pp. e23842.Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461

Record details

Read More Add to Saved list
×
Academic Journal

Kynurenine-AhR reduces T-cell infiltration and induces a delayed T-cell immune response by suppressing the STAT1-CXCL9/CXCL10 axis in tuberculosis.

  • Authors : Liu X; Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.; Yang M

Subjects: Kynurenine*/Kynurenine*/Kynurenine*/metabolism ; STAT1 Transcription Factor*/STAT1 Transcription Factor*/STAT1 Transcription Factor*/metabolism ; Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/metabolism

  • Source: Cellular & molecular immunology [Cell Mol Immunol] 2024 Dec; Vol. 21 (12), pp. 1426-1440. Date of Electronic Publication: 2024 Oct 22.Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality.

  • Authors : Giamarellos-Bourboulis EJ; 4(th) Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece; Hellenic Institute for the Study of Sepsis, Athens, Greece. Electronic address: .

Subjects: Sepsis*/Sepsis*/Sepsis*/mortality ; Sepsis*/Sepsis*/Sepsis*/immunology ; Sepsis*/Sepsis*/Sepsis*/blood

  • Source: EBioMedicine [EBioMedicine] 2024 Nov; Vol. 109, pp. 105414. Date of Electronic Publication: 2024 Oct 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Poly I:C vaccination drives transient CXCL9 expression near B cell follicles in the lymph node through type-I and type-II interferon signaling.

  • Authors : Ball AG; Department of Microbiology Cancer Biology and Immunology, University of Virginia, Charlottesville, VA 22903, USA; Carter Immunology Center and UVA Cancer Center, University of Virginia, Charlottesville, VA 22903, USA.

Subjects: Chemokine CXCL9*/Chemokine CXCL9*/Chemokine CXCL9*/metabolism ; Poly I-C*/Poly I-C*/Poly I-C*/pharmacology ; Lymph Nodes*/Lymph Nodes*/Lymph Nodes*/immunology

  • Source: Cytokine [Cytokine] 2024 Nov; Vol. 183, pp. 156731. Date of Electronic Publication: 2024 Aug 20.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005353 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection.

  • Authors : Mačionienė E; Institute of Clinical Medicine, Gastroenterology, Nephro-Urology and Surgery Clinic, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; Simanavičius M

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Chemokine CXCL10*/Chemokine CXCL10*/Chemokine CXCL10*/urine ; Graft Rejection*/Graft Rejection*/Graft Rejection*/urine

  • Source: Annals of transplantation [Ann Transplant] 2024 Oct 15; Vol. 29, pp. e944762. Date of Electronic Publication: 2024 Oct 15.Publisher: International Scientific Literature, Inc Country of Publication: United States NLM ID: 9802544 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  2,487 results for ""Chemokine CXCL9""